ÂÜÀòÂÒÂ×

Dr. Michael Garrison serves as executive vice president and president of the Medical Segment of BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. In this role, he is responsible for driving the global operational, commercial and financial performance of the three business units that comprise BD’s largest segment, including BD Medication Delivery Solutions, BD Medication Management Solutions and BD Pharmaceutical Systems. He is also a member of the BD Executive Leadership Team.

Dr. Garrison most recently served as worldwide president of BD Medication Management Solutions. In this role, he advanced BD 2025 priorities and drove growth through next-generation solutions supporting BD’s commitment to Smart, Connected Care and New Care Settings. He also led the team responsible for advancing BD’s 510(k) submission for Alaris. Additionally, he oversaw several successful tuck-in M&A deals, including the recent acquisition of Parata Systems – BD’s largest acquisition since Bard in 2017.

Since joining BD in 2005, Dr. Garrison has led teams with deep industry knowledge, operational excellence and a global view. He has a track record of building high-performing teams, applying a customer perspective to his work and driving growth. He previously served as worldwide president of the BD Surgery business unit, vice president and general manager of Infusion Systems, vice president of Research and Development (R&D) for BD Medication Delivery Solutions and Greater Asia and other earlier roles in R&D and platform leadership.

Dr. Garrison earned a Ph.D. in Bioengineering from the University of Washington and Bachelor and Master of Science degrees in Biomedical and Electrical Engineering from Duke University. He is an associate adjunct professor of Bioengineering at the University of Washington and a member of the University of Washington Department of Bioengineering Industrial Advisory Board and the Advisory Board of the Center for Dialysis Innovation.

Dr. Garrison is also a member of the Board of Governors for Biocom California, the association representing the California life sciences industry.